Linezolid cerebrospinal fluid concentration in central nervous system infection

P Malacarne1, B Viaggi, A DI Paolo

  • 1U.O. Anestesia e Rianimazione, Azienda Ospedaliera Universitaria Pisana, Pisa, Italy. pmalacarne@hotmail.com

Insights

Linezolid effectively treated central nervous system infections in one case but failed to reach therapeutic cerebrospinal fluid concentrations in another. Monitoring drug levels is recommended for linezolid in CNS infections.

Area of Science:

  • Infectious Diseases
  • Neuroscience
  • Pharmacology

Background:

  • Central nervous system (CNS) infections require effective antimicrobial therapy.
  • Methicillin-resistant Staphylococcus epidermidis (MRSE) can cause severe CNS infections.
  • Linezolid is a potential treatment option for resistant bacterial infections.

Observation:

  • Two cases of MRSE CNS infections treated with linezolid are presented.
  • Case 1: A 72-year-old woman with ventriculitis showed clinical and microbiological improvement with linezolid.
  • Case 2: A 27-year-old man with a cerebral abscess did not achieve detectable cerebrospinal fluid (CSF) linezolid levels despite high serum concentrations.

Findings:

  • Linezolid achieved therapeutic concentrations in CSF in the first case (trough levels > MIC).
  • Linezolid was undetectable in CSF and cerebral tissue in the second case, despite high serum levels.
  • This suggests variable penetration of linezolid into the CNS.

Implications:

  • Linezolid's efficacy in CNS infections may be limited by poor CSF penetration.
  • Monitoring of linezolid drug levels in CSF is crucial for optimizing treatment in CNS infections.
  • Further research is needed to understand factors influencing linezolid's CNS penetration and to guide its use in neuroinfectious diseases.

Related Concept Videos

Drug Delivery: Parenteral Route01:29

Drug Delivery: Parenteral Route

The parenteral route is a critical method of drug administration. It delivers compounds directly into the systemic circulation and bypasses the gastrointestinal tract. This approach is particularly advantageous for drugs that exhibit poor absorption or instability when administered orally.
There are three primary parenteral routes: intravenous (IV), intramuscular (IM), and subcutaneous (SC). The IV route introduces the drug directly into the bloodstream, ensuring immediate action. The IM route...
Cryptococcal Meningitis01:27

Cryptococcal Meningitis

Cryptococcal meningitis is a life-threatening opportunistic infection predominantly associated with HIV/AIDS, accounting for over 100,000 deaths annually worldwide. However, it also affects individuals with other forms of immunosuppression, including those undergoing immunosuppressive therapy, organ transplant recipients, patients with innate immunodeficiencies, and individuals with hematological disorders. The infection is caused mainly by Cryptococcus neoformans and Cryptococcus gattii,...
Cerebrospinal Fluid01:21

Cerebrospinal Fluid

Cerebrospinal fluid (CSF) is a colorless liquid that flows around the brain and the spinal cord, playing a vital role in the protection, support, and overall function of the central nervous system (CNS). CSF production, circulation, and absorption are tightly regulated processes essential for the brain and spinal cord to function properly.
CSF Production
CSF is produced mainly in the choroid plexus, a network of capillaries and ependymal cells located within the ventricular system of the brain.
Brain Abscess l: Introduction01:26

Brain Abscess l: Introduction

A brain abscess is a focal, intracerebral infection characterized by a localized collection of pus within the brain parenchyma, resulting from microbial invasion and the body’s inflammatory response. It progresses through stages: early and late cerebritis, followed by early and late capsule formation, reflecting tissue destruction, immune response, and eventual encapsulation.Etiology and PathogenesisCausative organisms vary with source and host factors, often involving polymicrobial infections,...
Bacterial Meningitis II: Pathophysiology01:26

Bacterial Meningitis II: Pathophysiology

Bacterial meningitis typically begins when pathogens such as Neisseria meningitidis and Streptococcus pneumoniae colonize the nasopharynx and invade the bloodstream. This process is facilitated by bacterial virulence factors, such as polysaccharide capsules, which resist phagocytosis and complement-mediated killing. Less commonly, bacteria reach the central nervous system via contiguous spread from infections like otitis media or sinusitis, through congenital or acquired dural defects, or...